×
Back to Agenda
Session 3 : Utilization of the J-PACMP system for Cell and Gene Therapy Products
Session Chair(s)
Teruyo Arato, PhD
Professor, Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Japan
Ryutaro Hirasawa
CMC Regulatory Affairs, Associate Director, Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
jun Matsumoto
Review Director, Department of Cellular and tissue derived products, Pharmaceutical and Medical Devices Agency, Japan
Yuriko Ishii
Associate Director, CMC Reguratory Affairs Department, Daiichi Sankyo Co., Ltd, Japan
Keigo Kawabe
Quality Officer, Regenerative & Cellular Medicine Office, Sumitomo Pharma Co.,Ltd., Japan
Naoyuki Hanada
Regulatory CMC, Novartis Pharma K.K., Japan
Have an account?